Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 4088-4103

  Jung, Carla S ^a   Wispel, Christian ^a   Zweckberger, Klaus ^a   Beynon, Christopher ^a   Hertle, Daniel ^a   Sakowitz, Oliver W ^a   Unterberg, Andreas W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute traumatic brain injury; Asymmetric dimethylarginine; Controlled cortical impact; Dimethylarginine dimethylaminohydrolases; Nitric oxide synthase; Protein arginine methyltransferases

Indexed keywords

DIMETHYLARGININASE; N (G), N (G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN ARGININE METHYLTRANSFERASE; UNCLASSIFIED DRUG; AMIDASE; ARGININE; N,N-DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRMT1 PROTEIN, RAT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID; CLIMBING; CONTROLLED STUDY; CRANIOTOMY; IMMUNOHISTOCHEMISTRY; LIMB MOVEMENT; MALE; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NONHUMAN; PROPRIOCEPTION; PROTEIN EXPRESSION; RAT; STRETCHING; SUBARACHNOID HEMORRHAGE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

AMIDOHYDROLASES; ANIMALS; ARGININE; BRAIN INJURIES; IMMUNOHISTOCHEMISTRY; MALE; MOTOR ACTIVITY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN-ARGININE N-METHYLTRANSFERASES; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84896463269     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15034088     Document Type: Article

References (45)

1. Furchgott, R. F.; Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288, 373-376.
2. Cherian, L.; Hlatky, R.; Robertson, C. S. Nitric oxide in traumatic brain injury. Brain Pathol. 2004, 14, 195-201.
3. Pluta, R. M.; Oldfield, E. H. Analysis of nitric oxide (no) in cerebral vasospasm after aneursymal bleeding. Rev. Recent Clin. Trials 2007, 2, 59-67.
4. Knowles, R. G.; Moncada, S. Nitric oxide synthases in mammals. Biochem. J. 1994, 298, 249-258.
5. Leiper, J.; Vallance, P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res. 1999, 43, 542-548.
6. Vallance, P.; Leone, A.; Calver, A.; Collier, J.; Moncada, S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339, 572-575.
7. Gahm, C.; Holmin, S.; Mathiesen, T. Nitric oxide synthase expression after human brain contusion. Neurosurgery 2002, 50, 1319-1326.
8. Lu, Y. C.; Liu, S.; Gong, Q. Z.; Hamm, R. J.; Lyeth, B. G. Inhibition of nitric oxide synthase potentiates hypertension and increases mortality in traumatically brain-injured rats. Mol. Chem. Neuropathol. 1997, 30, 125-137.
9. Mesenge, C.; Verrecchia, C.; Allix, M.; Boulu, R. R.; Plotkine, M. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma 1996, 13, 209-214.
10. Stoffel, M.; Rinecker, M.; Plesnila, N.; Eriskat, J.; Baethmann, A. Role of nitric oxide in the secondary expansion of a cortical brain lesion from cold injury. J. Neurotrauma 2001, 18, 425-434.
11. Cherian, L.; Chacko, G.; Goodman, C.; Robertson, C. S. Neuroprotective effects of L-arginine administration after cortical impact injury in rats: Dose response and time window. J. Pharmacol. Exp. Ther. 2003, 304, 617-623.
12. Cherian, L.; Chacko, G.; Goodman, J. C.; Robertson, C. S. Cerebral hemodynamic effects of phenylephrine and L-arginine after cortical impact injury. Crit. Care Med. 1999, 27, 2512-2517.
13. DeWitt, D. S.; Smith, T. G.; Deyo, D. J.; Miller, K. R.; Uchida, T.; Prough, D. S. L-arginine and superoxide dismutase prevent or reverse cerebral hypoperfusion after fluid-percussion traumatic brain injury. J. Neurotrauma 1997, 14, 223-233.
14. Hlatky, R.; Lui, H.; Cherian, L.; Goodman, J. C.; O'Brien, W. E.; Contant, C. F.; Robertson, C. S. The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice. J. Neurotrauma 2003, 20, 995-1006.
15. Wada, K.; Chatzipanteli, K.; Busto, R.; Dietrich, W. D. Role of nitric oxide in traumatic brain injury in the rat. J. Neurosurg. 1998, 89, 807-818.
16. Martens-Lobenhoffer, J.; Sulyok, E.; Czeiter, E.; Buki, A.; Kohl, J.; Firsching, R.; Troger, U.; Bode-Boger, S. M. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. J. Neurosci. Methods 2007, 164, 155-160.
17. Shlosberg, D.; Benifla, M.; Kaufer, D.; Friedman, A. Blood-brain barrier breakdown as a therapeautic target in traumatic brain injury. Nat. Rev. Neurol. 2010, 6, 393-403.
18. Henninger, N.; Sicard, K. M.; Li, Z.; Kulkarni, P.; Dutzmann, S.; Urbanek, C.; Schwab, S.; Fisher, M. Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit. Care Med. 2007, 35, 2607-2614.
19. Kline, A. E.; Massucci, J. L.; Zafonte, R. D.; Dixon, C. E.; DeFeo, J. R.; Rogers, E. H. Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Crit. Care Med. 2007, 35, 919-924.
20. Maegele, M.; Lippert-Gruener, M.; Ester-Bode, T.; Sauerland, S.; Schafer, U.; Molcanyi, M.; Lefering, R.; Bouillon, B.; Neiss, W. F.; Angelov, D. N.; et al. Reversal of neuromotor and cognitive dysfunction in an enriched environment combined with multimodal early onset stimulation after traumatic brain injury in rats. J. Neurotrauma 2005, 22, 772-782.
21. Garcia, J. H.; Wagner, S.; Liu, K. F.; Hu, X. J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26, 627-634; discussion 635.
22. Tang, J.; Frankel, A.; Cook, R. J.; Kim, S.; Paik, W. K.; Williams, K. R.; Clarke, S.; Herschman, H. R. Prmt1 is the predominant type i protein arginine methyltransferase in mammalian cells. J. Biol. Chem. 2000, 275, 7723-7730.
23. Gahm, C.; Holmin, S.; Mathiesen, T. Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion. Neurosurgery 2000, 46, 169-177.
24. Wada, K.; Chatzipanteli, K.; Kraydieh, S.; Busto, R.; Dietrich, W. D. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 1998, 43, 1427-1436.
25. Clark, R. S.; Kochanek, P. M.; Schwarz, M. A.; Schiding, J. K.; Turner, D. S.; Chen, M.; Carlos, T. M.; Watkins, S. C. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr. Res. 1996, 39, 784-790.
26. Akaike, T.; Maeda, H. Quantification of nitric oxide using 2-phenyl-4, 4, 5, 5-tetramethylimidazoline-1-oxyl 3-oxide (ptio). Methods Enzymol. 1996, 268, 211-221.
27. Jung, C. S.; Iuliano, B. A.; Harvey-White, J.; Espey, M. G.; Oldfield, E. H.; Pluta, R. M. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J. Neurosurg. 2004, 101, 836-842.
28. Jung, C. S.; Oldfield, E. H.; Harvey-White, J.; Espey, M. G.; Zimmermann, M.; Seifert, V.; Pluta, R. M. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2007, 107, 945-950.
29. Thampatty, B. P.; Klamerus, M. M.; Oberly, P. J.; Feldman, K. L.; Bell, M. J.; Tyler-Kabara, E. C.; Adelson, P. D.; Clark, R. S.; Kochanek, P. M.; Poloyac, S. M. Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury. Pediatr. Crit. Care Med. 2013, 14, 403-412.
30. Zhang, X.; Chen, Y.; Jenkins, L. W.; Kochanek, P. M.; Clark, R. S. B. Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit. Care 2005, 9, 66-75.
31. Wada, K.; Chatzipanteli, K.; Busto, R.; Dietrich, W. D. Effects of L-name and 7-ni on nos catalytic activity and behavioral outcome after traumatic brain injury in the rat. J. Neurotrauma 1999, 16, 203-212.
32. Goksel, H. M.; Ozum, U.; Oztoprak, I. The therapeutic effect of continuous intracisternal L-arginine infusion on experimental cerebral vasospasm. Acta Neurochir. (Wien.) 2001, 143, 277-285.
33. Pluta, R. M.; Afshar, J. K.; Thompson, B. G.; Boock, R. J.; Harvey-White, J.; Oldfield, E. H. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J. Neurosurg. 2000, 92, 121-126.
34. Huk, I.; Nanobashvili, J.; Neumayer, C.; Punz, A.; Mueller, M.; Afkhampour, K.; Mittlboeck, M.; Losert, U.; Polterauer, P.; Roth, E.; et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997, 96, 667-675.
35. Yamaguchi, A.; Kitajo, K. The effect of prmt1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of fus/tls. PLoS One 2012, 7, e49267.
36. Tran, C. T.; Fox, M. F.; Vallance, P.; Leiper, J. M. Chromosomal localization, gene structure, and expression pattern of ddah1: Comparison with ddah2 and implications for evolutionary origins. Genomics 2000, 68, 101-105.
37. Ogawa, T.; Kimoto, M.; Sasaoka, K. Purification and properties of a new enzyme, ng, ng-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 1989, 264, 10205-10209.
38. Leiper, J. M.; Santa Maria, J.; Chubb, A.; MacAllister, R. J.; Charles, I. G.; Whitley, G. S.; Vallance, P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 1999, 34, 209-214.
39. Amrouni, D.; Meiller, A.; Gautier-Sauvigne, S.; Piraud, M.; Bouteille, B.; Vincendeau, P.; Buguet, A.; Cespuglio, R. Cerebral changes occurring in arginase and dimethylarginine dimethylaminohydrolase (ddah) in a rat model of sleeping sickness. PLoS One 2011, 6, e16891.
40. Boger, R. H.; Sydow, K.; Borlak, J.; Thum, T.; Lenzen, H.; Schubert, B.; Tsikas, D.; Bode-Boger, S. M. Ldl cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: Involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 2000, 87, 99-105.
41. Ito, A.; Tsao, P. S.; Adimoolam, S.; Kimoto, M.; Ogawa, T.; Cooke, J. P. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999, 99, 3092-3095.
42. Immonen, R.; Heikkinen, T.; Tahtivaara, L.; Nurmi, A.; Stenius, T. K.; Puolivali, J.; Tuinstra, T.; Phinney, A. L.; van Vliet, B.; Yrjanheikki, J.; et al. Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury-Ccomparison with behavioral outcome. J. Cereb. Blood Flow Metab. 2010, 30, 1318-1328.
43. Linsky, T. W.; Fast, W. Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase. Bioorg. Med. Chem. 2012, 20, 5550-5558.
44. Nandi, M.; Kelly, P.; Torondel, B.; Wang, Z.; Starr, A.; Ma, Y.; Cunningham, P.; Stidwill, R.; Leiper, J. Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shock. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2589-2597.
45. Zweckberger, K.; Eros, C.; Zimmermann, R.; Kim, S. W.; Engel, D.; Plesnila, N. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J. Neurotrauma 2006, 23, 1083-1093.